SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the six months ended June 30, 2025 and 2024:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2025
Revenue	$	1,433,847		$	-		$	-		$	733,418		$	2,167,265
Cost of Sales		(1,254,761	)		-			-			(365,814	)		(1,620,575	)
Gross Profit		179,086			-			-			367,604			546,690
Operating Expenses		(1,378,493	)		(323,406	)		(402,049	)		(5,130,322	)		(7,234,269	)
Operating Loss		(1,199,407	)		(323,406	)		(402,049	)		(4,762,718	)		(6,687,579	)
Other Expense		(458,681	)		(881,753	)		(2,875,116	)		(7,399,957	)		(11,615,507	)
Net Loss Before Income Tax		(1,658,088	)		(1,205,159	)		(3,277,165	)		(12,162,675	)		(18,303,086	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Six Months Ended on June 30, 2024
Revenue	$	6,458,005		$	-		$	-		$	755,248		$	7,213,253
Cost of Sales		(5,181,322	)		-			(3,387	)		(303,616	)		(5,488,325	)
Gross Profit (Loss)		1,276,683			-			(3,387	)		451,632			1,724,928
Operating Expenses		(939,866	)		(290,635	)		(1,115,063	)		(4,455,348	)		(6,800,912	)
Operating Income (Loss)		336,817			(290,635	)		(1,118,450	)		(4,003,716	)		(5,075,984	)
Other Income (Expense)		422,319			(1,850,609	)		(99,845	)		(1,859,637	)		(3,387,772	)
Net Income (Loss) Before Income Tax		759,136			(2,141,244	)		(1,218,295	)		(5,863,353	)		(8,463,756	)
June 30, 2025
Cash and Restricted Cash	$	5,437,261		$	235,619		$	2,039,120		$	17,980,791		$	25,692,790
Total Assets		43,576,149			2,199,925			3,311,899			36,923,552			86,011,525
December 31, 2024
Cash and Restricted Cash	$	4,928,236		$	326,540		$	3,375,824		$	19,553,127		$	28,183,726
Total Assets		44,683,563			3,176,729			5,446,468			43,382,430		$	96,761,977